Loading...
  • antidepressant
  • Therapeutic Trials: Results of open and controlled trials in patients with depressive illness indicate that mianserin has antidepressant activity at dosages of 30 to 120mg daily in divided doses or as a single bedtime dose of 60mg. (ovid.com)
  • We present the first case of AGEP associated with the antidepressant, mianserin.A 46-year-old man, with no personal history of psoriasis, was admitted complaining of a generalized pruritic pustular eruption. (jle.com)
  • amitriptyline
  • It has an overall efficacy comparable with amitriptyline and imipramine in depressive illness, but at dosages which have achieved a similar overall clinical improvement, mianserin causes significantly fewer anticholinergic side effects than amitriptyline or imipramine and also appears less likely than these drugs to cause serious cardiotoxicity on overdosage. (ovid.com)
  • Unlike amitriptyline, mianserin did not produce postural hypotension in volunteers or adverse cardiovascular (ECG) effects in volunteers or depressed patients, including those with heart disease. (ovid.com)
  • The non-sedating agents imipramine and nortriptyline are Amitriptyline Clomipramine Dosulepin Doxepin Imipramine Lofepramine Mianserin. (buydiflucancvv.com)
  • tricyclic
  • Pharmacodynamic Studies: The profile of action of mianserin differs from that of the tricyclic antidepressants. (ovid.com)
  • In man, mianserin in therapeutic dosage has no effect on peripheral noradrenaline uptake in the tyramine pressor test, and unlike the tricyclic antidepressants does not significantly decrease the antihypertensive action of bethanidine or guanethidine. (ovid.com)